Literature DB >> 7274235

Beneficial effect of enhanced myocardial carbohydrate utilisation after oxfenicine (L-hydroxyphenylglycine) in angina pectoris.

G Bergman, L Atkinson, J Metcalfe, N Jackson, D E Jewitt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7274235     DOI: 10.1093/oxfordjournals.eurheartj.a061126

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  12 in total

Review 1.  Free fatty acid metabolism during myocardial ischemia and reperfusion.

Authors:  S C Hendrickson; J D St Louis; J E Lowe; S Abdel-aleem
Journal:  Mol Cell Biochem       Date:  1997-01       Impact factor: 3.396

Review 2.  Metabolic approaches to the treatment of ischemic heart disease: the clinicians' perspective.

Authors:  Andrew A Wolff; Heschi H Rotmensch; William C Stanley; Roberto Ferrari
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

3.  Deranged Cardiac Metabolism and the Pathogenesis of Heart Failure.

Authors:  Gabriele Fragasso
Journal:  Card Fail Rev       Date:  2016-05

4.  Modification of left ventricular hypertrophy by chronic etomixir treatment.

Authors:  M Turcani; H Rupp
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

5.  Effects of amino acids on substrate selection, anaplerosis, and left ventricular function in the ischemic reperfused rat heart.

Authors:  M E Jessen; T E Kovarik; F M Jeffrey; A D Sherry; C J Storey; R Y Chao; W S Ring; C R Malloy
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

6.  Two mechanisms produce tissue-specific inhibition of fatty acid oxidation by oxfenicine.

Authors:  T W Stephens; A J Higgins; G A Cook; R A Harris
Journal:  Biochem J       Date:  1985-04-15       Impact factor: 3.857

7.  Haemodynamic and metabolic effects of dazoxiben at rest and during atrial pacing.

Authors:  P S Kiff; G Bergman; L Atkinson; D E Jewitt; J Westwick; V V Kakkar
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

8.  Beneficial effects of diltiazem in coronary artery disease.

Authors:  J Kenny; K Daly; G Bergman; S Kerkez; D E Jewitt
Journal:  Br Heart J       Date:  1984-07

Review 9.  A pathophysiological compass to personalize antianginal drug treatment.

Authors:  Edoardo Bertero; Gerd Heusch; Thomas Münzel; Christoph Maack
Journal:  Nat Rev Cardiol       Date:  2021-07-07       Impact factor: 32.419

Review 10.  New directions in the treatment of heart failure: targeting free fatty acid oxidation.

Authors:  Gabriele Fragasso; Roberto Spoladore; Giorgio Bassanelli; Amarild Cuko; Chiara Montano; Anna Salerno; Alberto Margonato
Journal:  Curr Heart Fail Rep       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.